Precigen (STU:I5X) Cyclically Adjusted FCF per Share: €-0.64 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:I5X Precigen Inc STU:I5X
55 GF Score
Price €6.05
GF Value €14.65
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Precigen Cyclically Adjusted FCF per Share?

Precigen STU:I5X +6.14% 55 Cyclically Adjusted FCF per Share is €-0.64 as of Jun. 2026. GuruFocus rates STU:I5X with a GF Score™ of 55/100 and a GF Value™ of €14.65 (Possible Value Trap). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Precigen's adjusted free cash flow per share for the three months ended in Jun. 2026 was €-0.038. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.64 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 17.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Precigen was 37.10% per year. The lowest was 17.30% per year. And the median was 27.20% per year.

As of today (2026-08-06), Precigen's current stock price is €6.05. Precigen's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was €-0.64. Precigen's Cyclically Adjusted Price-to-FCF of today is .


Precigen  (STU:I5X) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Precigen Cyclically Adjusted FCF per Share Related Terms


Precigen Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Precigen's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precigen Cyclically Adjusted FCF per Share Chart

Precigen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.33 -1.09 -0.61 -0.40 -0.65

Precigen Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.53 -0.63 -0.65 -0.63 -0.64

STU:I5X vs GLUE, ZBIO, ADMA: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Precigen's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precigen Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precigen's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Precigen's Cyclically Adjusted Price-to-FCF falls into.


STU:I5X
55GF Score
Precigen Inc STU:I5X
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precigen Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Precigen's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.038/333.9520*333.9520
=-0.038

Current CPI (Jun. 2026) = 333.9520.

Precigen Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.195 241.428 -0.270
201612 -0.229 241.432 -0.317
201703 -0.244 243.801 -0.334
201706 -0.261 244.955 -0.356
201709 -0.254 246.819 -0.344
201712 -0.335 246.524 -0.454
201803 -0.258 249.554 -0.345
201806 -0.258 251.989 -0.342
201809 -0.249 252.439 -0.329
201812 -0.325 251.233 -0.432
201903 -0.317 254.202 -0.416
201906 -0.272 256.143 -0.355
201909 -0.205 256.759 -0.267
201912 0.228 256.974 0.296
202003 -0.174 258.115 -0.225
202006 -0.085 257.797 -0.110
202009 -0.103 260.280 -0.132
202012 -0.083 260.474 -0.106
202103 -0.076 264.877 -0.096
202106 -0.037 271.696 -0.045
202109 -0.082 274.310 -0.100
202112 -0.077 278.802 -0.092
202203 -0.093 287.504 -0.108
202206 -0.041 296.311 -0.046
202209 -0.128 296.808 -0.144
202212 -0.073 296.797 -0.082
202303 -0.075 301.836 -0.083
202306 -0.059 305.109 -0.065
202309 -0.065 307.789 -0.071
202312 -0.062 306.746 -0.067
202403 -0.068 312.332 -0.073
202406 -0.094 314.175 -0.100
202409 -0.077 315.301 -0.082
202412 -0.030 315.605 -0.032
202503 -0.053 319.799 -0.055
202506 -0.058 322.561 -0.060
202509 -0.082 324.800 -0.084
202512 -0.057 324.054 -0.059
202603 -0.108 330.213 -0.109
202606 -0.038 333.952 -0.038

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.64 mean?
Precigen (STU:I5X) has a Cyclically Adjusted FCF per Share of €-0.64 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Precigen and its competitors.
Is Precigen's Cyclically Adjusted FCF per Share too high?
Precigen's current Cyclically Adjusted FCF per Share is €-0.64. Overall, Precigen has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Precigen's Cyclically Adjusted FCF per Share compare to GLUE and ZBIO?
Precigen's Cyclically Adjusted FCF per Share of €-0.64 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Precigen and its competitors. Precigen's current Cyclically Adjusted FCF per Share is €-0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precigen stock overvalued right now?
Based on GuruFocus' analysis, Precigen (STU:I5X) is currently considered Possible Value Trap. The stock's GF Value™ is €14.65, compared to a current price of €6.05 — trading 58.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-0.64. Precigen's overall GF Score™ is 55/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Precigen (STU:I5X), the current Cyclically Adjusted FCF per Share is €-0.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precigen (STU:I5X) Overvalued in 2026?

Based on GuruFocus' analysis, Precigen stock appears to be undervalued. The current stock price of €6.05 is trading 58.7% below its estimated GF Value™ of €14.65. GuruFocus considers Precigen to be Possible Value Trap.

Key valuation signals for STU:I5X:

  • Cyclically Adjusted FCF per Share: €-0.64
  • GF Value™: €14.65 vs. price of €6.05 (58.7% below fair value)
  • GF Score™: 55/100 with 9 warning signs

No single metric tells the full story. See the STU:I5X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Precigen Business Description

Other Exchanges PGEN:USA
Address 20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
55GF Score

Get the complete analysis for STU:I5X

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.05
Price
€14.65
GF Value